Eisai Co., Ltd. · Tokyo Japan
| 4-6-10 Koishikawa, Bunkyo-Ku | Phone: +81-3-3817-3700 |
| Tokyo | Fax: +81-3-3811-3077 |
| 112-8088 | |
| Japan | 
Map This Company |
Eisai Co., Ltd. Rankings
| Nikkei 225 |
Company Description
Eisai develops, manufactures, and distributes prescription pharmaceuticals, primarily in North America and Japan. Prescription drug sales account for a majority of the company's revenues and are led by Aricept, which treats Alzheimer's disease. Other drugs include Myonal, a muscle relaxant, and Pariet (known as AcipHex in the US) an acid reflux and ulcer treatment. Development programs target neurology, oncology, vascular, and immunological ailments. In addition, in Japan Eisai distributes over-the-counter drugs and consumer health products. The company also makes chemical active pharmaceutical ingredients (APIs).
Eisai Co., Ltd. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | PublicHeadquarters |
|---|---|
| Fiscal Year-End | March |
| 2011 Employees | 11,560 |
Executives
37 executives listed for Eisai Co., Ltd.'s Tokyo, Japan location.